ArticleProductwise 3-2-1Here's the next edition of our monthly bite-sized digest, Productwise 3-2-1 where each month, we'll be bringing to the top of your inbox (and your agenda):United StatesConsumer ProtectionCooley LLP
ArticleRejection Time: On February 20th The Supreme Court Hears Oral Argument On The Big Question In The Tempnology Case — Does A Trademark Licensee Lose Its Rights Upon Rejection?The Big Question. What is the effect of rejection of a trademark license by a debtor-licensor? Over the past few years, this blog has followed the Tempnology case out of New Hampshire raising just that issue. United StatesIntellectual PropertyCooley LLP
ArticleEuropean Commission Issues UK Adequacy DecisionsOn 28 June 2021, the European Commission issued two adequacy decisions in respect of the UK – one under Regulation (EU) 2016/679 (the EU's General Data Protection Regulation, or EU GDPR) and ...European UnionPrivacyCooley LLP
ArticleDisruption Caused By COVID-19We all hope that the predictions about the spread and seriousness of COVID-19 (coronavirus) prove to be unfounded. GlobalComplianceCooley LLP
ArticleEPO Extends Most Deadlines In Response To COVID‑19 PandemicThe European Patent Office (EPO) has announced that it will be extending some deadlines to 17 April 2020, and that this date may be further extended. United KingdomCoronavirus (COVID-19)Cooley LLP
ArticleUK National Security And Investment Bill Receives Royal AscentOn 29 April 2021, the UK National Security and Investment Bill, which strengthens the UK government's ability to investigate transactions on grounds of national security, was granted Royal Ascent.United KingdomGovernment, Public SectorCooley LLP
ArticleSBA Programs Under The CARES Act: ‘Affiliation' Interim Final Rules And GuidanceA key feature of the CARES Act $2 trillion relief package is the creation of the Paycheck Protection Program (PPP), which authorizes $349 billion for businesses to obtain loans of up to $10 million...United StatesCoronavirus (COVID-19)Cooley LLP
ArticleCorp Fin Posts Sample Comment Letter On XBRLCorp Fin has posted a sample comment letter to companies about their XBRL disclosures. I don't pretend to know or understand a thing about XBRL, much less Inline XBRL...United StatesCorporate/Commercial LawCooley LLP
ArticleCorp Fin Urges Redaction Of Personally Identifiable Information From Rule 14a-8 SubmissionsThe staff tries to redact this information before making the materials publicly available, but that process can delay posting of these materials.United StatesCorporate/Commercial LawCooley LLP
ArticleCMS Releases Guidance Allowing Step Therapy For Part B DrugsToday, the Centers for Medicare & Medicaid Services (CMS) released guidance and a Fact Sheet that will provide Medicare Advantage (MA) plans the option of utilizing "step therapy" United StatesFood, Drugs, Healthcare, Life SciencesCooley LLP
ArticleCash for the CrashWith uncertainty continuing surrounding the UK's proposed exit from the EU, the UK government is offering grants of £25,000 or more to help UK businesses prepare for the implications of a "no-deal"United StatesGovernment, Public SectorCooley LLP
ArticleTrials And Tribulations: Minimising The Risk Of Disputes Arising From Clinical Trial AgreementsThe Clinical Trials Regulation (‘CTR'), which came into force last year, has modified (and in some cases increased) responsibilities for sponsors, streamlined reporting processes...United StatesLitigation, Mediation & ArbitrationCooley LLP
ArticleInundated With Requests Under New Jersey's Daniel's Law?A flood of class action lawsuits have been filed against companies alleging violations of New Jersey's Daniel's Law. United StatesPrivacyCooley LLP
ArticleTransitional Tax Reporting Guidance For Business Transactions Involving Digital AssetsIn Announcement 2024-4, the IRS and the US Department of the Treasury stated that, until regulations are issued, taxpayers will not be required to treat digital assets received in the course of their trade or business as cash.United StatesTaxCooley LLP
ArticlePublic Companies Update – April One-Minute ReadsOn March 14, 2023, the Securities and Exchange Commission announced settled charges against DXC Technology, an IT services company...United StatesComplianceCooley LLP
ArticleCooley's 2019 Tech M&A Year In ReviewIn the wake of record-setting volume and value metrics in 2018, practitioners eyed the 2019 deal market with healthy skepticism.United StatesCorporate/Commercial LawCooley LLP
ArticleProductwise 3-2-1 (August, 2020)Here's the next edition of our monthly bite-sized digest, Productwise 3-2-1 where each month, we'll be bringing to the top of your inbox (and your agenda):United StatesConsumer ProtectionCooley LLP
ArticleProductwise 3-2-1 (29 October 2021)Productwise 3-2-1, our monthly bite-sized digest of the current key issues in products law.GlobalConsumer ProtectionCooley LLP
ArticleThe Beginning Of A Process: How Europe's New Consumer Agenda Will Reshape The Future Of Product Regulation"It's the beginning of a process, not the end". These are the words of European Commissioner for Justice, Didier Reynders this week, when answering questions from the European Parliament...European UnionConsumer ProtectionCooley LLP
ArticleEuropean Commission Publishes Updated Q&A On Clinical Trials RegulationIn December 2022, the European Commission published an updated version of the Q&A guidance on the Clinical Trials Regulation.European UnionFood, Drugs, Healthcare, Life SciencesCooley LLP